concept

SYNUCLEINOPATHY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SYNUCLEINOPATHY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

480Connections

0Hypotheses

2Analyses

50Outgoing

50Incoming

0Experiments

2Debates

Summary

SYNUCLEINOPATHY is a concept in neurodegeneration research. Key relationships include: activates, associated with, therapeutic target. Associated with Aging, Als, Alzheimer. Connected to 118 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	SYNUCLEINOPATHY
Key Genes/Proteins	ACHE, AGING, ALPHA-SYNUCLEIN, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID
Related Diseases	Aging, Als, ALS, Alzheimer, Anxiety
Related Pathways	Alpha-Synuclein, Amyloid

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Synucleinopathy Mechanism

mechanism · 4870 words

→

Pathway Diagram

graph TD
    SYNUCLEINOPATHY["SYNUCLEINOPATHY"]
    SYNUCLEINOPATHY -->|"inhibits"| Synucleinopathy["Synucleinopathy"]
    SYNUCLEINOPATHY -->|"activates"| Neurodegeneration["Neurodegeneration"]
    SYNUCLEINOPATHY -->|"inhibits"| Tauopathy["Tauopathy"]
    SYNUCLEINOPATHY -->|"activates"| Autophagy["Autophagy"]
    SYNUCLEINOPATHY -->|"activates"| Phagocytosis["Phagocytosis"]
    SYNUCLEINOPATHY -->|"activates"| Immune_Response["Immune Response"]
    SYNUCLEINOPATHY -->|"activates"| ASTROCYTE["ASTROCYTE"]
    SYNUCLEINOPATHY -->|"inhibits"| ALPHA_SYNUCLEIN["ALPHA-SYNUCLEIN"]
    SYNUCLEINOPATHY -->|"inhibits"| TAU["TAU"]
    SYNUCLEINOPATHY -->|"activates"| AMYLOID_BETA["AMYLOID-BETA"]
    BMAL1["BMAL1"] -->|"inhibits"| SYNUCLEINOPATHY
    BAG3["BAG3"] -->|"activates"| SYNUCLEINOPATHY
    CLOCK["CLOCK"] -->|"activates"| SYNUCLEINOPATHY
    TFR1["TFR1"] -->|"activates"| SYNUCLEINOPATHY
    GPX4["GPX4"] -->|"activates"| SYNUCLEINOPATHY
    MLKL["MLKL"] -->|"activates"| SYNUCLEINOPATHY
    RIPK3["RIPK3"] -->|"activates"| SYNUCLEINOPATHY
    GENES["GENES"] -->|"activates"| SYNUCLEINOPATHY
    CTSD["CTSD"] -->|"activates"| SYNUCLEINOPATHY
    SNCA["SNCA"] -->|"activates"| SYNUCLEINOPATHY

Outgoing (216)

Target	Relation	Type	Str
Neurodegeneration	activates	disease	0.75
Synucleinopathy	therapeutic_target	disease	0.75
Parkinson	activates	disease	0.75
Synucleinopathy	associated_with	disease	0.75
Parkinson	associated_with	disease	0.75
Synucleinopathy	activates	disease	0.75
Als	causes	disease	0.75
Neurodegeneration	causes	disease	0.75
Neurodegeneration	causes	disease	0.65
Parkinson	inhibits	disease	0.65
Ms	regulates	disease	0.65
Synucleinopathy	causes	disease	0.65
Neurodegeneration	expressed_in	disease	0.65
Als	expressed_in	disease	0.65
Neurodegeneration	phosphorylates	disease	0.65
Inflammation	activates	disease	0.65
Alzheimer	causes	disease	0.65
Neurodegeneration	inhibits	disease	0.65
Tauopathy	activates	disease	0.65
Ataxia	inhibits	disease	0.65
Parkinson	causes	disease	0.65
Parkinson	regulates	disease	0.65
Neurodegeneration	regulates	disease	0.65
Synucleinopathy	regulates	disease	0.65
ALS	activates	disease	0.65
Lewy Body	associated_with	disease	0.65
Als	inhibits	disease	0.65
Parkinson	phosphorylates	disease	0.65
Inflammation	inhibits	disease	0.65
Aging	inhibits	disease	0.65
Neuroinflammation	inhibits	disease	0.65
Als	associated_with	disease	0.65
Alzheimer	associated_with	disease	0.65
Neuroinflammation	activates	disease	0.65
Ms	inhibits	disease	0.65
Neuroinflammation	regulates	disease	0.65
Tauopathy	associated_with	disease	0.65
Neurodegeneration	associated_with	disease	0.65
Dementia	associated_with	disease	0.65
Inflammation	regulates	disease	0.65
Anxiety	associated_with	disease	0.65
Senescence	inhibits	disease	0.65
Ms	activates	disease	0.65
Neuroinflammation	associated_with	disease	0.65
Aging	associated_with	disease	0.65
Ms	therapeutic_target	disease	0.65
Synucleinopathy	inhibits	disease	0.65
Synucleinopathy	expressed_in	disease	0.65
Parkinson	activates	disease	0.65
Tauopathy	inhibits	disease	0.65

Incoming (264)

Source	Relation	Type	Str
SNCA	associated_with	gene	0.90
PARKINSON'S DISEASE	activates	gene	0.85
PARKINSON	activates	gene	0.75
SYNUCLEINOPATHY	activates	gene	0.75
SYNUCLEINOPATHY	therapeutic_target	gene	0.75
Parkinson	associated_with	disease	0.75
ALPHA-SYNUCLEIN	activates	gene	0.75
NEURODEGENERATIVE DISEASES	activates	gene	0.75
NEURODEGENERATION	activates	gene	0.75
NEUROINFLAMMATION	activates	gene	0.75
NEURODEGENERATION	causes	gene	0.75
PARKINSON'S DISEASE	associated_with	gene	0.75
PARKINSON	associated_with	gene	0.75
SYNUCLEINOPATHY	associated_with	gene	0.75
PARKINSON	associated_with	gene	0.70
SNCA	causes	gene	0.70
PARKINSON'S DISEASE	associated_with	gene	0.70
TNF-α	associated_with	protein	0.70
NEURODEGENERATION	activates	gene	0.70
ALPHA-SYNUCLEIN	activates	gene	0.70
PARKINSON	activates	gene	0.70
PARKINSON'S DISEASE	activates	gene	0.70
CGAS	associated_with	gene	0.65
STING	associated_with	gene	0.65
MLKL	activates	gene	0.65
BAG3	activates	gene	0.65
INPP5F	associated_with	gene	0.65
GENES	activates	gene	0.65
PARKINSON	causes	gene	0.65
TMEM175	associated_with	gene	0.65
DNA	associated_with	gene	0.65
GPX4	activates	gene	0.65
AUTOPHAGY	activates	gene	0.65
ALZHEIMER	causes	gene	0.65
SNCA-AS1	associated_with	gene	0.65
NURR1	activates	gene	0.65
SCARB2	associated_with	gene	0.65
BMAL1	inhibits	gene	0.65
GBA	associated_with	gene	0.65
ALPHA-SYNUCLEIN	inhibits	gene	0.65
TNF-Α	therapeutic_target	gene	0.65
TAU	activates	gene	0.65
NEURODEGENERATION	therapeutic_target	gene	0.65
TNF	therapeutic_target	gene	0.65
GAN	therapeutic_target	gene	0.65
TFR1	activates	gene	0.65
AMYLOID-BETA	activates	gene	0.65
PHAGOCYTOSIS	activates	gene	0.65
AMYLOID	activates	gene	0.65
ASTROCYTES	activates	gene	0.65

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

What determines the specificity of DDR protein recruitment to dilncRNA-induced c

neurodegeneration | 2026-04-08 | 0 hypotheses

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

neurodegeneration | 2026-04-03 | 42 hypotheses Top: 0.914

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

While the study shows 53BP1 forms phase-separated foci driven by dilncRNAs, it's

closed · Rounds: 7 · Score: 0.95 · 2026-04-10

What gene expression changes in the aging mouse brain predict neurodegenerative

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Related Research

Hypotheses and analyses mentioning SYNUCLEINOPATHY in their description or question text

No additional research found